Clinical Trials Directory

Trials / Completed

CompletedNCT02975895

Outcome of Different IOLs in Patients With and Without Uveitis

Outcome With Hydrophobic and Hydrophilic Intraocular Lens in Patients With and Without Uveitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Vastra Gotaland Region · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cataract, is a clouding of the lens in the eye gradually leading to reduction of the visual acuity. In most cases it can be managed with surgery, removing the own lens and replacing it with an artificial lens, intraocular lens (IOL). These lenses are made in different materials with different properties. Uveitis refers to an inflammation in the iris, ciliary body and choroid. Patients with this disease have an increased risk of developing cataract due to the inflammation itself and treatment with steroids. They also have an increased risk of complications during surgery and postoperatively. In this group the selection of IOL might be of greater importance. The aim of this prospective randomized controlled study is to compare the outcome of hydrophobic and hydrophilic intraocular lenses in patients with and without uveitis

Conditions

Interventions

TypeNameDescription
DEVICEHydrophobic IOL: Vivinex (HOYA)Patients requiring cataract surgery will be randomized to one of the two types of IOLs.
DEVICEHydrophilic IOL: INCISE (Bausch+Lomb)Patients requiring cataract surgery will be randomized to one of the two types of IOLs.

Timeline

Start date
2016-12-30
Primary completion
2021-02-22
Completion
2022-03-17
First posted
2016-11-29
Last updated
2023-08-30

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02975895. Inclusion in this directory is not an endorsement.